Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 14512832)

1.

Network Neurodegeneration in Alzheimer's Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing.

Miller MI, Ratnanather JT, Tward DJ, Brown T, Lee DS, Ketcha M, Mori K, Wang MC, Mori S, Albert MS, Younes L; BIOCARD Research Team.

Front Bioeng Biotechnol. 2015 May 15;3:54. doi: 10.3389/fbioe.2015.00054. eCollection 2015.

2.

Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.

Tomadesso C, Perrotin A, Mutlu J, Mézenge F, Landeau B, Egret S, de la Sayette V, Jonin PY, Eustache F, Desgranges B, Chételat G.

Neuroimage Clin. 2015 May 28;8:473-82. doi: 10.1016/j.nicl.2015.05.010. eCollection 2015.

3.

Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Lu Y, Wang MC, Selnes O, Albert M, Brown T, Ratnanather JT, Younes L, Miller MI; BIOCARD Research Team.

Hum Brain Mapp. 2015 Jul;36(7):2826-41. doi: 10.1002/hbm.22810. Epub 2015 Apr 16.

PMID:
25879865
4.

Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.

Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Lee DS, Tward D, Mahon PB, Mori S, Albert M; BIOCARD Research Team.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S3-S10. doi: 10.1016/j.neurobiolaging.2014.06.032. Epub 2014 Aug 29.

5.

Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease.

Younes L, Albert M, Miller MI; BIOCARD Research Team.

Neuroimage Clin. 2014 Apr 21;5:178-87. doi: 10.1016/j.nicl.2014.04.009. eCollection 2014.

6.

Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.

Tang X, Holland D, Dale AM, Younes L, Miller MI; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2014 Aug;35(8):3701-25. doi: 10.1002/hbm.22431. Epub 2014 Jan 17.

7.

Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging.

Nir TM, Jahanshad N, Villalon-Reina JE, Toga AW, Jack CR, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neuroimage Clin. 2013 Jul 27;3:180-95. doi: 10.1016/j.nicl.2013.07.006. eCollection 2013.

8.

Alzheimer's disease clinical and research update for health care practitioners.

Defina PA, Moser RS, Glenn M, Lichtenstein JD, Fellus J.

J Aging Res. 2013;2013:207178. doi: 10.1155/2013/207178. Epub 2013 Sep 4. Review.

9.

Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease.

Vounou M, Janousova E, Wolz R, Stein JL, Thompson PM, Rueckert D, Montana G; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Mar;60(1):700-16. doi: 10.1016/j.neuroimage.2011.12.029. Epub 2011 Dec 22.

10.

Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation.

Irish M, Lawlor BA, Coen RF, O'Mara SM.

BMC Neurosci. 2011 Aug 4;12:80. doi: 10.1186/1471-2202-12-80.

11.

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.

12.

Nonlinear registration of longitudinal images and measurement of change in regions of interest.

Holland D, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Med Image Anal. 2011 Aug;15(4):489-97. doi: 10.1016/j.media.2011.02.005. Epub 2011 Feb 23.

13.

A review of the brain structure correlates of successful cognitive aging.

Kaup AR, Mirzakhanian H, Jeste DV, Eyler LT.

J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):6-15. doi: 10.1176/appi.neuropsych.23.1.6. Review.

14.

Subregional neuroanatomical change as a biomarker for Alzheimer's disease.

Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20954-9. Erratum in: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6551. Fenema-Notestine, Christine [corrected to Fennema-Notestine, Christine].

15.

Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM, The Alzheimer's Disease Neuroimaging Initiative.

Behav Neurol. 2009;21(1):3-12. doi: 10.3233/BEN-2009-0230. Review.

16.

Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease.

Calvini P, Chincarini A, Gemme G, Penco MA, Squarcia S, Nobili F, Rodriguez G, Bellotti R, Catanzariti E, Cerello P, De Mitri I, Fantacci ME; MAGIC-5 Collaboration; Alzheimer's Disease Neuroimaging Initiative.

Med Phys. 2009 Aug;36(8):3737-47.

17.

High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment.

Kovacevic S, Rafii MS, Brewer JB; Alzheimer's Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):139-45. doi: 10.1097/WAD.0b013e318192e745.

18.

Structural MRI biomarkers for preclinical and mild Alzheimer's disease.

Fennema-Notestine C, Hagler DJ Jr, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2009 Oct;30(10):3238-53. doi: 10.1002/hbm.20744.

19.

Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease.

Desikan RS, Cabral HJ, Fischl B, Guttmann CR, Blacker D, Hyman BT, Albert MS, Killiany RJ.

AJNR Am J Neuroradiol. 2009 Mar;30(3):532-8. doi: 10.3174/ajnr.A1397. Epub 2008 Dec 26.

20.

Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia.

Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC.

Ann Neurol. 2005 Jun;57(6):896-903.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk